Today, Lonza is a global leader in life sciences operating across five continents. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together, devising
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Position summary Remote, Based in Switzerland Territory: Germany and Austria Travel: 50% About the Role We are seeking a highly driven Business Development Director with a strong hunter mentality to expand our presence across the German and
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Line of ServiceAdvisory Industry/SectorFS X-Sector SpecialismEmerging Technologies Management LevelDirector Job Description & SummaryPwC and Microsoft maintain a strategic global alliance focused on delivering AI driven innovation and transformation across Cloud & AI Platforms, Security, and AI Business
Celonis is the global leader in Process Intelligence and the pioneer of Process Mining technology. As one of the world’s fastest-growing enterprise SaaS companies, we are changemakers pushing the boundaries of what’s possible. We invest heavily
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Senior Director, Finance – CIO Group, Operations & Technology About CIO, Operations & Technology Do you want to shape how a global technology organisation invests, scales, and delivers impact? Join Thomson Reuters as a strategic finance partner
VF Corporation is looking for an exceptional Director, POS, Omnichannel, Marketplace Engineering to join our Digital and Data Technology team based in Stabio, Swithzerland. Let’s talk about the role! The Director, POS, Omnichannel and Marketplace Engineering is a
Salary Range:CHF164,500.00 - CHF305,500.00 Job Description SummaryLocation Basel, Switzerland #LI-Hybrid 3 days/week in office Internal Job Title: The Executive Director, Applied AI Lead Novartis is making a significant long-term investment in becoming an AI-first organization, with sponsorship
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF164,500.00 - CHF305,500.00 BandLevel 7 Job Description SummaryLocation Basel, Switzerland #LI-Hybrid 3 days/week in office Internal Job Title: The Executive Director, Applied AI Lead Novartis is making a significant long-term investment in becoming an AI-first organization,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Location: Geneva Contract: Fixed Term or consultancy at 100% - The term of this assignment is intended to be for a period of three (3) years, nevertheless, the duration of the contract may be subject to